Chief Medical and Scientific Advisor
Rachel Sherman is applying her expertise in regulatory science and medical product evaluation and approval to address client challenges at all stages of product development, both nationally and internationally.
Rachel has 30 years of experience with the US Food and Drug Administration, most recently serving as Principal Deputy Commissioner of Food and Drugs. As a board-certified internist with a specialty in infectious diseases, she is recognized for innovative, patient-centered approaches to addressing complex policy issues and dedicated mentoring. Rachel is a nationally respected thought leader with principal roles across a broad range of complex subject matter, including real world evidence, combination products, rare diseases, biosimilars, infectious diseases, good clinical practice, prescription drug promotion and active post-market surveillance systems.
Rachel received her MD from Mount Sinai School of Medicine, MPH from Johns Hopkins University and undergraduate degree from Washington University in St. Louis. She completed her residency at Montefiore Hospital and Medical Center and fellowship in Infectious Diseases at Mount Sinai Hospital.